Article Figures & Data
Tables
- Table 1.
Prevalence of iciHHV-6 status according to sex and cancer prevalence from CARTaGENE
Sex n (%) iciHHV-6−N (%) iciHHV-6+N (%; 95% CI) Males 9,560 (48.78) 9,496 (48.74) 64 (0.33; 0.47–0.67) Females 10,037 (51.22) 9,988 (51.26) 49 (0.25; 0.34–0.53) Total 19,597 (100) 19,484 (99.42) 113 (0.58) Cancer type iciHHV-6−N = 19,484 (%) iciHHV-6+N = 113 (%) Pa iciHHV-6− males n = 9,496 (%) iciHHV-6+ males n = 64 (%) Pa iciHHV-6− females n = 9,988 (%) iciHHV-6+ females n = 49 (%) Pa OR (95% CI) Cancer (all) 1,553 (7.97) 12 (10.62) 0.38 621 (6.54) 5 (7.81) 0.86 932 (9.33) 7 (14.29) 0.34 1.63 (0.73–3.62) Breast 326 (1.67) 4 (3.54) 0.24 3 (0.03) 0 (0.00) ND 323 (3.23) 4 (8.16) 0.12 2.66 (0.95–7.44) Skin 327 (1.68) 0 (0.00) 0.31 152 (1.60) 0 (0.00) 0.60 175 (1.75) 0 (0.00) 0.70 0.56 (0.03–9.20) Prostate 177 (0.91) 1 (0.88) 0.64 177 (1.86) 1 (1.56) 0.84 N/A N/A N/A N/A Cervix 124 (0.64) 0 (0.00) 0.80 N/A N/A N/A 124 (1.24) 0 (0.00) 0.80 0.80 (0.04–13.06) Abbreviations: N/A, not applicable; ND, not determined (too few cases).
↵aFisher exact test.
- Table 2.
Prevalence of iciHHV-6 according to case–control status in the CBCS
Controls (n = 1,053) Cases (n = 1,090) Mean age (years + SD) at enrollment/diagnosis P 56.90 ± 10.10 57.30 ± 10.30 0.21a iciHHV-6 prevalence OR (95% CI) iciHHV-6− 1,043 (99.05) 1,081 (99.18) iciHHV-6+ 10 (0.95) 9 (0.82) 0.94b 0.87 (0.35–2.15)
March 2017
Volume 26, Issue 3
Volume 26, Issue 3
Inherited Chromosomally Integrated Human Herpesvirus 6 and Breast Cancer
Jump to section
Advertisement